BioStem Technologies, Inc. (NASDAQ:BSEM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark A. Glickman Other companies: MetaVia Inc. (Independent Director · Since at least May 11, 2023); TherapeuticsMD, Inc. (Co-Chief Executive Officer · Oct 15, 2021 – Dec 6, 2022 · Past); Esperion Therapeutics, Inc. (Chief Commercial Officer · Dec 20, 2018 – Jan 2, 2020 · Past); Aralez Pharmaceuticals Inc (Chief Commercial Officer · Feb 5, 2016 – Mar 19, 2018 · Past); POZEN Inc (Chief Commercial Officer · Jun 22, 2015 – Jun 22, 2015 · Past); Auxilium Pharmaceuticals Inc (EVP - Sales and Marketing · Feb 3, 2012 – Jan 29, 2015 · Past) | Director · Since at least Aug 6, 2026 |
| Andrew Van Vurst | Chief Operating Officer · Since at least Nov 5, 2026 |
| Barry Hassett | Chief Commercial Officer · Since at least Nov 3, 2026 |
| Brandon Poe | Chief Financial Officer · Since at least Aug 6, 2026 |
| Hannaway Rayna Lesser | Director · Since at least Aug 6, 2026 |
| Jason Matuszewski | Chief Executive Officer · Since at least Nov 5, 2026 |
| Jeff Humke | Vice President of Human Resources · Since at least Nov 4, 2026 |
| Jodi Ungrodt | Director · Since at least Aug 6, 2026 |
| Katherine Gorrell | Chief Legal and Compliance Officer · Since at least Nov 5, 2026 |
| Kenneth Howard Warrington Jr | Director · Since at least Aug 6, 2026 |
| Lita Lilly | Vice President of Sales · Since at least Nov 5, 2026 |
| Michael Fortunato | Chief Accounting Officer · Since at least Aug 6, 2026 |
| Noah Agron | Vice President of Corporate Finance and Strategy · Since at least Nov 5, 2026 |
| Steven D Sonenreich | Director · Since at least Aug 6, 2026 |
| Vicky Oxley | Vice President of Marketing · Since at least Nov 4, 2026 |
| Vurst Andrew Smith-Van | Chief Operating Officer, Director · Since at least Aug 6, 2026 |
| Wendy W. Weston | Vice President of Research and Development · Since at least Nov 5, 2026 |